WEIGHT LOSS SPECIALIST – DHA LAHORE
Daily GLP-1 injection for appetite control and long-term weight management – prescribed by specialist in DHA Lahore.
ساکسینڈا (Liraglutide) ایک روزانہ لگایا جانے والا انجیکشن ہے جو بھوک کو قابو میں رکھتا ہے اور وزن میں مستقل کمی لاتا ہے۔ ڈاکٹر رضوان نیازی ہر مریض کی مکمل جانچ کے بعد اسے تجویز کرتے ہیں۔
Saxenda is a once-daily injectable GLP-1 receptor agonist containing Liraglutide at 3.0 mg – the highest dose approved for weight management. It is the same molecule used in Victoza for diabetes, but at a higher dose specifically for obesity treatment.
Clinical trials show 8–9% body weight reduction over 56 weeks. It is often recommended as an established, well-studied option for patients who require a daily injection schedule.
Saxenda activates GLP-1 receptors to reduce hunger, slow digestion, and improve blood sugar – supporting steady, long-term weight loss.
Acts on hunger centres in the brain to reduce food intake throughout the day – helping patients maintain a calorie deficit.
Delays how quickly food leaves the stomach, extending feelings of fullness after every meal.
Daily dosing provides consistent hormone activity throughout the day, reducing appetite spikes between meals.
Saxenda is FDA-approved and has been in clinical use for over a decade. Specialist supervision is required for safe and effective use.
Nausea, vomiting, diarrhoea, constipation, and headache are most common in the early weeks. These usually improve as the body adjusts.
Not recommended for patients with thyroid cancer history, MEN2, pancreatitis, or severe renal/hepatic impairment. Assessment is essential.
Saxenda has over 10 years of real-world clinical data and is considered safe under proper specialist supervision.
Book a consultation with Dr. Rizwan Niazi for a full evaluation and personalised prescription plan.
Dr. Rizwan also prescribes the following injections based on individual patient assessment.
ⓘ All injections are prescribed based on individual assessment under proper medical supervision.
Saxenda must be prescribed and monitored by a qualified specialist. Proper dose titration and regular follow-ups are essential for both safety and long-term results.
Medical history, BMI, medications, and metabolic markers are reviewed before prescribing Saxenda.
Dose adjustments and progress tracking are scheduled monthly for the first few months of treatment.
Blood tests confirm suitability and track response throughout the course of treatment.
Saxenda, Mounjaro, and Wegovy each suit different patient profiles. A consultation with Dr. Rizwan Niazi identifies the safest and most effective option for your goals.
Saxenda (Liraglutide 3.0 mg) is a once-daily GLP-1 injection that reduces appetite, slows digestion, and helps patients maintain a lower calorie intake for sustained weight loss.
Clinical trials show approximately 8–9% body weight reduction over 56 weeks. Results vary based on diet, lifestyle, starting weight, and individual response to the medication.
Yes. Saxenda is available and can be prescribed by a qualified specialist. Dr. Rizwan Niazi prescribes it following a full clinical assessment at his clinic in DHA Lahore.
Saxenda is a daily injection with a well-established safety record. Wegovy (Semaglutide) is weekly with higher average weight loss. Mounjaro (Tirzepatide) targets two receptors and delivers the highest average results. The right choice depends on your medical profile.
The most common side effects are nausea, vomiting, diarrhoea, constipation, and headache – especially during the dose escalation phase. Most side effects reduce over time.
Yes. Saxenda is a prescription-only medication. A full clinical assessment by a qualified doctor is required before starting treatment.